Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Organ preservation in rectal adenocarcinoma (T1) T2-T3 Nx M0. Historical overview of the Lyon Sud - nice experience using contact x-ray brachytherapy and external beam radiotherapy for 120 patients.

Gerard JP, Frin AC, Doyen J, Zhou FX, Gal J, Romestaing P, Barbet N, Coquard R, Chapet O, François E, Marcié S, Benezery K.

Acta Oncol. 2015 Apr;54(4):545-51. doi: 10.3109/0284186X.2014.975840. Epub 2014 Nov 12. No abstract available.

PMID:
25389568
2.

Numerus clausus et démographie médicale en France.

Huguier M, Romestaing P.

Bull Acad Natl Med. 2014 Oct;198(7):1367-78. French.

PMID:
27120909
3.

Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.

Hennequin C, Bossard N, Servagi-Vernat S, Maingon P, Dubois JB, Datchary J, Carrie C, Roullet B, Suchaud JP, Teissier E, Lucardi A, Gerard JP, Belot A, Iwaz J, Ecochard R, Romestaing P.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):860-6. doi: 10.1016/j.ijrobp.2013.03.021. Epub 2013 May 9. Erratum in: Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1145. Erratum in: Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1145.

PMID:
23664327
4.

Towards a "Lyon molecular signature" to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signature.

Gérard JP, Baulieux J, Doyen J, Gal J, Letouze E, Olschwang S, Chapet O, Romestaing P.

Cancer Radiother. 2012 Dec;16(8):688-96. doi: 10.1016/j.canrad.2012.09.003. Epub 2012 Nov 13.

PMID:
23153504
5.

XIAP as a radioresistance factor and prognostic marker for radiotherapy in human rectal adenocarcinoma.

Moussata D, Amara S, Siddeek B, Decaussin M, Hehlgans S, Paul-Bellon R, Mornex F, Gerard JP, Romestaing P, Rödel F, Flourie B, Benahmed M, Mauduit C.

Am J Pathol. 2012 Oct;181(4):1271-8. doi: 10.1016/j.ajpath.2012.06.029. Epub 2012 Aug 4.

6.

[Small DCIS: Excision alone].

Romestaing P.

Gynecol Obstet Fertil. 2012 Jun;40(6):387-9. doi: 10.1016/j.gyobfe.2012.04.004. Epub 2012 May 31. French. No abstract available.

PMID:
22658905
7.

Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.

Ortholan C, Romestaing P, Chapet O, Gerard JP.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):e165-71. doi: 10.1016/j.ijrobp.2011.12.002.

PMID:
22579379
8.

Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no hysterectomy in patients with a (clinical and radiological) complete response after chemoradiation therapy for stage IB2 or II cervical cancer.

Morice P, Rouanet P, Rey A, Romestaing P, Houvenaeghel G, Boulanger JC, Leveque J, Cowen D, Mathevet P, Malhaire JP, Magnin G, Fondrinier E, Berille J, Haie-Meder C.

Oncologist. 2012;17(1):64-71. doi: 10.1634/theoncologist.2011-0276. Epub 2012 Jan 10.

9.

[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma].

Remonnay R, Morelle M, Pommier P, Haie-Meder C, Quetin P, Kerr C, Delannes M, Castelain B, Peignaux K, Kirova Y, Romestaing P, Williaume D, Krzisch C, Thomas L, Lang P, Baron MH, Cussac A, Lesaunier F, Maillard S, Barillot I, Charra-Brunaud C, Carrère MO, Peiffert D.

Cancer Radiother. 2010 Jun;14(3):161-8. doi: 10.1016/j.canrad.2009.11.004. Epub 2010 Mar 4. French.

PMID:
20206571
10.

Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.

Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, De Lafontan B, Zoubir M, Maingon P, Mignotte H, de Lara CT, Edeline J, Penault-Llorca F, Romestaing P, Delva C, Comet B, Belkacemi Y.

Crit Rev Oncol Hematol. 2010 Mar;73(3):246-54. doi: 10.1016/j.critrevonc.2009.04.002. Epub 2009 May 12.

PMID:
19442535
11.

Building a shared patient record for breast cancer management: a French Delphi study.

Letrilliart L, Milliat-Guittard L, Romestaing P, Schott AM, Berthoux N, Colin C.

Eur J Cancer Care (Engl). 2009 Mar;18(2):131-9. doi: 10.1111/j.1365-2354.2007.00887.x.

PMID:
19267728
12.

Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study.

Falandry C, Debled M, Bachelot T, Delozier T, Crétin J, Romestaing P, Mille D, You B, Mauriac L, Pujade-Lauraine E, Freyer G.

Breast Cancer Res Treat. 2009 Aug;116(3):501-8. doi: 10.1007/s10549-008-0229-5. Epub 2008 Nov 20.

PMID:
19020973
13.

[Irradiation of lymph nodes areas in breast cancer].

Hennequin C, Romestaing P, Maylin C.

Cancer Radiother. 2008 Nov;12(6-7):559-64. doi: 10.1016/j.canrad.2008.07.016. French.

PMID:
18951822
14.

[Ductal carcinoma in situ: role of the boost].

Azria D, Auvray H, Barillot I, Baumann P, Benyoucef A, Bons-Rosset F, Bontemps P, Bourgier C, Breton-Callu C, Cowen D, Cretin J, Delalande B, Denis F, Ellis S, Gaci Z, Hannoun-Lévy JM, Hasbini A, Hennequin C, Lagrange JL, Lartigau E, Latorzeff I, Le Blanc-Onfroy M, Lecouillard I, Lemanski C, Levy C, Maingon P, Marchal C, Monnier A, Pradier O, Racadot S, Romestaing P, Serin D, Simon JM, Teyssier E, Tallet A, Tolédano A, Belkacémi Y.

Cancer Radiother. 2008 Nov;12(6-7):571-6. doi: 10.1016/j.canrad.2008.07.005. Epub 2008 Aug 13. Review. French.

PMID:
18703372
15.

[Patient-held health records: impact on breast cancer follow-up in the Rhône-Alpes region. Project Archimed].

Milliat-Guittard L, Romestaing P, Letrilliart L, Berthoux N, Charlois AL, Mere P, Schott AM, Colin C.

Rev Epidemiol Sante Publique. 2008 Jul;56 Suppl 3:S239-46. doi: 10.1016/j.respe.2008.04.009. Epub 2008 Jun 9. French.

PMID:
18538965
16.

[Initial management of gynecologic cancers: reference guides of the Société Française d'Oncologie Gynécologique (SFOG) ].

Querleu D, Bonnier P, Morice P, Narducci F, Lhomme C, Haie-Meder C, Aubard Y, Baldauf JJ, Barillot I, Castelain B, Cuisenier J, Duvillard P, Genestie C, Houvenaeghel G, Leblanc E, Lefranc JP, Lejeune C, Mathevet P, Pautier P, Romestaing P, Tubiana N, Villet R; Société Française d'Oncologie Gynécologique.

Gynecol Obstet Fertil. 2008 Mar;36(3):338-52. French. No abstract available.

PMID:
18494150
17.

Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial.

Heudel P, Romestaing P, Barbet N, Falandry C, You B, Glehen O, Freyer G.

Clin Oncol (R Coll Radiol). 2008 Jun;20(5):369-74. doi: 10.1016/j.clon.2008.02.011. Epub 2008 Apr 11.

PMID:
18406583
18.

Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03).

Tournier-Rangeard L, Mercier M, Peiffert D, Gerard JP, Romestaing P, Lemanski C, Mirabel X, Pommier P, Denis B.

Radiother Oncol. 2008 Jun;87(3):391-7. doi: 10.1016/j.radonc.2007.12.004. Epub 2008 Jan 11.

PMID:
18191265
19.

French experience with contact X-ray endocavitary radiation for early rectal cancer.

Gerard JP, Chapet O, Ortholan C, Benezery K, Barbet N, Romestaing P.

Clin Oncol (R Coll Radiol). 2007 Nov;19(9):661-73. Epub 2007 Sep 5. Review.

PMID:
17822887
20.

Differential effects of ionizing radiation and platinum-derivative chemotherapy on apoptotic pathways in testicular germ cells.

Chater S, Amara S, Moussata D, Bozec A, Omezzine A, Romestaing P, Chapet O, Gerard JP, Mornex F, Benahmed M, Mauduit C.

Int J Radiat Biol. 2007 Apr;83(4):269-78.

PMID:
17575954
21.

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review.

Bonadona V, Dussart-Moser S, Voirin N, Sinilnikova OM, Mignotte H, Mathevet P, Brémond A, Treilleux I, Martin A, Romestaing P, Raudrant D, Rudigoz RC, Lenoir GM, Lasset C.

Breast Cancer Res Treat. 2007 Jan;101(2):233-45. Epub 2006 Oct 24.

PMID:
17061047
22.

Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.

Petit T, Velten M, d'Hombres A, Marchal C, Montbarbon X, Mornex F, Quetin P, Gérard JP, Romestaing P, Carrie C.

Gynecol Oncol. 2007 Jan;104(1):104-8. Epub 2006 Sep 20.

PMID:
16987544
23.

Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes.

Chapet O, Khodri M, Jalade P, N'guyen D, Flandin I, D'hombres A, Romestaing P, Mornex F.

Radiother Oncol. 2006 Sep;80(3):333-40. Epub 2006 Aug 24.

PMID:
16934354
24.

The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage.

Brem R, Cox DG, Chapot B, Moullan N, Romestaing P, Gérard JP, Pisani P, Hall J.

Carcinogenesis. 2006 Dec;27(12):2469-74. Epub 2006 Jul 8.

PMID:
16829685
25.

Prognostic factors of squamous cell carcinoma of the anal margin treated by radiotherapy: the Lyon experience.

Chapet O, Gerard JP, Mornex F, Goncalves-Tavan S, Ardiet JM, D'hombres A, Favrel V, Romestaing P.

Int J Colorectal Dis. 2007 Feb;22(2):191-9. Epub 2006 Mar 31.

PMID:
16799791
26.

[Influence of the delay between conservative surgery and radiation therapy on local relapse in node-positive breast tumor].

Benchalal M, Boisselier P, de Lafontan B, Berton-Rigaud D, Belkacemi Y, Romestaing P, Peignaux K, Courdi A, Monnier A, Montcuquet P, Goudier MJ, Marchal C, Chollet P, Abadie-Lacourtoisie S, Datchary J, Veyret C, Kerbrat P.

Bull Cancer. 2006 Mar 1;93(3):303-13. French.

27.

[Exchanges of medical information during the follow up of breast cancer patients: perceptions and expectations of the community- and the hospital based practitioners].

Milliat-Guittard L, Letrilliart L, Galand-Desmé S, Berthoux N, Charlois AL, Romestaing P, Méré P, Schott AM, Touzet S, Colin C.

Bull Cancer. 2006 Feb;93(2):223-31. French.

28.
29.

Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group results.

Fumoleau P, Roché H, Kerbrat P, Bonneterre J, Romestaing P, Fargeot P, Namer M, Monnier A, Montcuquet P, Goudier MJ, Luporsi E; French Adjuvant Study Group.

Ann Oncol. 2006 Jan;17(1):85-92. Epub 2005 Oct 26.

30.

[A French survey on breast radiotherapy techniques for simulation and treatment].

Fournier-Bidoz N, Rosenwald JC, Romestaing P.

Cancer Radiother. 2005 Nov;9(6-7):399-401. Epub 2005 Oct 12. French.

PMID:
16226471
31.

[Parcours de femmes 2001, a French survey on the management and needs of women with breast and gynecological cancer: what's new after 8 years?].

Serin D, Dilhuydy JM, Guiochet N, Romestaing P, Gledhill J, Bret P, Savary J, Flinois A.

Bull Cancer. 2005 Sep;92(9):817-27. French.

32.

[Radiotherapy optimization in breast cancer: filtration, electronic compensation, intensity modulation].

Corsetti D, Bellière A, Romestaing P.

Cancer Radiother. 2005 Nov;9(6-7):411-3. Epub 2005 Sep 19. Review. French.

PMID:
16176885
33.

Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer.

Chapet O, Gerard JP, Riche B, Alessio A, Mornex F, Romestaing P.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1316-24. Epub 2005 Sep 19.

PMID:
16169674
34.

[Excision of low rectal carcinomas with sphincter preservation. Multimodal strategy using neoadjuvant radiotherapy and "delayed" coloanal anastomosis without defunctioning stoma].

Baulieux J, Mabrut JY, Adham M, de La Roche E, Olagne E, Ducerf C, Romestaing P, Gerard JP.

Bull Acad Natl Med. 2004;188(9):1509-24; discussion 1524-7. French.

PMID:
15997621
35.

Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.

Benchalal M, Le Prisé E, de Lafontan B, Berton-Rigaud D, Belkacemi Y, Romestaing P, Peignaux K, Courdi A, Monnier A, Montcuquet P, Goudier MJ, Marchal C, Chollet P, Abadie-Lacourtoisie S, Datchary J, Veyret C, Kerbrat P.

Cancer. 2005 Jul 15;104(2):240-50.

36.

Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group.

Campone M, Roché H, Kerbrat P, Bonneterre J, Romestaing P, Fargeot P, Namer M, Monnier A, Montcuquet P, Goudier MJ, Fumoleau P.

Ann Oncol. 2005 Aug;16(8):1343-51. Epub 2005 May 19.

37.

Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.

Ortholan C, Ramaioli A, Peiffert D, Lusinchi A, Romestaing P, Chauveinc L, Touboul E, Peignaux K, Bruna A, de La Roche G, Lagrange JL, Alzieu C, Gerard JP.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):479-85.

PMID:
15890590
38.

Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.

Bonadona V, Sinilnikova OM, Chopin S, Antoniou AC, Mignotte H, Mathevet P, Brémond A, Martin A, Bobin JY, Romestaing P, Raudrant D, Rudigoz RC, Léoné M, Chauvin F, Easton DF, Lenoir GM, Lasset C.

Genes Chromosomes Cancer. 2005 Aug;43(4):404-13.

PMID:
15887246
39.

Effect of radiotherapy on pelvic lymph node metastasis in cervical cancer stages IB2-IVA: a retrospective analysis of two comparative series.

Dargent D, Lamblin G, Romestaing P, Montbarbon X, Mathevet P, Benchaib M.

Int J Gynecol Cancer. 2005 May-Jun;15(3):468-74.

40.

Preoperative radiotherapy for rectal adenocarcinoma: Which are strong prognostic factors?

Chapet O, Romestaing P, Mornex F, Souquet JC, Favrel V, Ardiet JM, d'Hombres A, Gerard JP.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1371-7.

PMID:
15817339
41.

Overview of the role of preoperative radiotherapy to increase sphincter preservation for rectal cancer.

Gerard JP, Romestaing P, Chapet O, Baulieux J.

Front Radiat Ther Oncol. 2004;38:24-7. Review. No abstract available.

PMID:
15458183
42.

Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility.

Sinilnikova OM, Ginolhac SM, Magnard C, Léoné M, Anczukow O, Hughes D, Moreau K, Thompson D, Coutanson C, Hall J, Romestaing P, Gérard JP, Bonadona V, Lasset C, Goldgar DE, Joulin V, Venezia ND, Lenoir GM.

Carcinogenesis. 2004 Dec;25(12):2417-24. Epub 2004 Aug 27.

PMID:
15333468
43.
44.

Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial.

Gerard JP, Chapet O, Nemoz C, Hartweig J, Romestaing P, Coquard R, Barbet N, Maingon P, Mahe M, Baulieux J, Partensky C, Papillon M, Glehen O, Crozet B, Grandjean JP, Adeleine P.

J Clin Oncol. 2004 Jun 15;22(12):2404-9.

PMID:
15197202
45.

[Lymphatic mapping and inguinal sentinel lymph node biopsy in anal canal cancers to avoid prophylactic inguinal irradiation].

Bobin JY, Gérard JP, Chapet O, Romestaing P, Isaac S.

Cancer Radiother. 2003 Nov;7 Suppl 1:85s-90s. French.

PMID:
15124549
46.

[To boost the tumor bed: the age of reason].

Maingon P, Chapet O, Barillot I, Romestaing P.

Cancer Radiother. 2004 Feb;8(1):33-8. Review. French.

PMID:
15093199
47.

[Cancer/radiotherapy].

Maingon P, Calais G, Fourquet A, Romestaing P.

Cancer Radiother. 2004 Feb;8(1):1. French. No abstract available.

PMID:
15093194
48.

[Ciliary body melanomas. Survival and prognostic aspects after brachytherapy or proton therapy].

Gambrelle J, Kodjikian L, Rouberol F, Donate D, Duquesne N, Jean-Louis B, Chauvel P, Gérard JP, Romestaing P, Grange JD.

J Fr Ophtalmol. 2004 Jan;27(1):40-7. French.

PMID:
14968076
49.

[Efficacy of argon plasma electrocoagulation to control bleeding from radiation-induced duodenitis].

Roman S, Lombard-Bohas C, Pereira A, Dumortier J, Romestaing P, Gilly FN, Ponchon T, Saurin JC.

Gastroenterol Clin Biol. 2003 Dec;27(12):1171-2. French. No abstract available.

50.

ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.

Angèle S, Romestaing P, Moullan N, Vuillaume M, Chapot B, Friesen M, Jongmans W, Cox DG, Pisani P, Gérard JP, Hall J.

Cancer Res. 2003 Dec 15;63(24):8717-25.

Supplemental Content

Loading ...
Support Center